Cellyan Biotechnology Co. Ltd (HKPD) is an Other Pharmaceuticals company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for HKPD, including 2 SEC filings and 1 press release or news item. The most recent was published Nov 12, 2026.
Financial highlights
Full financials- Revenue, FY2026
- $13.43M
- Revenue growth
- -33.9%
- Net income, FY2026
- -$1.14M
- Net margin
- -8.5%
- Free cash flow, FY2026
- -$787.1K
- Cash
- $221.8K
For fiscal 2026 (ended Mar 31, 2026), from SEC filings. Not investment advice.
News · 26 weeks20+50%
2026-05-172026-11-08
Mix690d
- SEC Filings5(83%)
- Other1(17%)
Activity · 52 weeks3021 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- PRCellyan Biotechnology Announces a 1-for-20 Reverse Stock SplitHONG KONG, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (NASDAQ:HKPD) (the "Company"), a leading provider of over-the-counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, announced that it expects to implement a 1-for-20 reverse stock split, or consolidation of its issued and unissued Class A ordinary shares and Class B ordinary shares, par value $0.001 per share (the "Ordinary Shares"), effective at the opening of market of October 26, 2026 (the "Reverse Stock Split"). Trading in the Class A Ordinary Shares on a split-adjusted basis will continue on Nasdaq on October 26, 2026 under the symbol "HKPD." The new CUSIP number for the Co
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form S-8 filed by Cellyan Biotechnology Co. LtdS-8 - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 20-F filed by Cellyan Biotechnology Co. Ltd20-F - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form NT 20-F filed by Cellyan Biotechnology Co. LtdNT 20-F - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- PRCellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace PeriodHONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (NASDAQ:HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the "Notification Letter") on July 14, 2026 from Nasdaq's Listing Qualifications Department indicating that the Company has been granted an additional 180 calendar day period, or until January 11, 2027, to regain compliance with the Nasdaq’s minimum $1.00 closing bid price requirement ("the Minimum Bid Price Requirement") as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. To rega
- SECSEC Form EFFECT filed by Cellyan Biotechnology Co. LtdEFFECT - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form F-3 filed by Cellyan Biotechnology Co. LtdF-3 - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- INSIDERSEC Form 3 filed by new insider Chan Kam Leung3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERNew insider Wong Lap Sun claimed ownership of 18,468 units of Class A Ordinary Shares (SEC Form 3)3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wang Zifeng3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Liu Shu3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Zhou Mike Yao3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wu Jingyan3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Liang Chenyu Andy3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- SECSEC Form EFFECT filed by Cellyan Biotechnology Co. LtdEFFECT - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form F-1 filed by Cellyan Biotechnology Co. LtdF-1 - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
HKPD FAQ
9 questionsWhat is the latest news on HKPD?
In the last 30 days Quantisnow tracked 3 wire items for HKPD: 2 SEC filings and 1 press release or news item. The most recent was published on November 12, 2026.What is HKPD revenue?
Cellyan Biotechnology Co. Ltd (HKPD) reported $13.43M of revenue for fiscal 2026 (ended Mar 31, 2026). That is down 33.9% from the year before.Is HKPD profitable?
No. Cellyan Biotechnology Co. Ltd reported a net loss of $1.14M for fiscal 2026 (ended Mar 31, 2026).How much cash and debt does HKPD have?
Cellyan Biotechnology Co. Ltd reported $221.8K in cash and cash equivalents and $877.9K of debt on its most recent balance sheet in SEC filings.Where does HKPD stock trade?
Cellyan Biotechnology Co. Ltd (HKPD) is listed on NASDAQ.What sector and industry is HKPD in?
Cellyan Biotechnology Co. Ltd operates in the Health Care sector, Other Pharmaceuticals industry.When did Cellyan Biotechnology Co. Ltd go public?
Cellyan Biotechnology Co. Ltd (HKPD) completed its IPO in 2025.What companies are similar to HKPD?
Notable peers in the same industry include ZSTK (ZeroStack Corp.), CAH (Cardinal Health Inc.), COSM (Cosmos Health Inc.), NUS (Nu Skin Enterprises Inc.), MCK (McKesson Corporation). Compare HKPD side-by-side with any of them on Quantisnow.How can I track HKPD on Quantisnow?
Quantisnow aggregates Cellyan Biotechnology Co. Ltd's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HKPD to receive live email and push alerts on every new disclosure.